Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019)

Ironwood Pharmaceuticals' (IRWD) quarterly Work In Process came in at $392000.0 in Q4 2019, down 44.55% quarter-over-quarter from $707000.0 in Q3 2019.

Ironwood Pharmaceuticals (IRWD) Work In Process (2016 - 2019) Analysis & Trends

Ironwood Pharmaceuticals has disclosed Work In Process across 2 years of filings, most recently posting $392000.0 for Q4 2019.

  • Work In Process for Q4 2019 came in at $392000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $392000.0 (changed N/A YoY), and the FY2019 annual result was $392000.0, changed N/A from the prior year.
  • Work In Process came in at $392000.0 for Q4 2019 at Ironwood Pharmaceuticals, down from $707000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $707000.0 in Q3 2019 to a low of $71000.0 in Q4 2016.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Ironwood Pharmaceuticals 526.31 Mn 305.84 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2019 392,000.00
Sep 30, 2019 707,000.00
Jun 30, 2019 260,000.00
Dec 31, 2016 71,000.00